It has been reported that PIK3A and PIK3R1, the genes that respectively encode the PI3K p110α and PI3K p85 subunits, are somatically mutated in many cancers, including liver cancer, and that these mutations promote the activation of the PI3K-AKT pathway and oncogenesis [34], [35]. Here, AKT1 is linked to liver cancer.